Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
07/12/2006 | EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
07/12/2006 | EP1678164A1 Substituted pyrazinone compounds for the treatment of inflammation |
07/12/2006 | EP1678156A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
07/12/2006 | EP1677830A2 Antagonists of the bradykinin b1 receptor |
07/12/2006 | EP1677816A1 Therapeutic method |
07/12/2006 | EP1677781A1 Salts of pharmacologically active compounds |
07/12/2006 | EP1677768A2 Extended release formulations of opioids and method of use thereof |
07/12/2006 | EP1516866B1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
07/12/2006 | EP1427730B1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
07/12/2006 | EP1419118B1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof |
07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
07/12/2006 | EP1150570B1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
07/12/2006 | EP1121439B1 Methods and compositions for inhibiting neoplastic cell growth |
07/12/2006 | EP0994719B1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
07/12/2006 | EP0971743B1 Stabilized medicaments containing cysteinyl derivatives |
07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
07/12/2006 | CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
07/12/2006 | CN1802178A Solid formulation |
07/12/2006 | CN1802166A Compositions for mucosal and oral administration comprising HCG fragments |
07/12/2006 | CN1800195A Chemical compound synthesized by carboxylic acid analog non-steroid anti-inflammatory agent and aminoglucose or its salt, and its synthesis method and uses |
07/12/2006 | CN1800182A N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity |
07/12/2006 | CN1800164A Kukoline C ring modified derivative and its synthesis method |
07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
07/12/2006 | CN1799623A Use of No. 21 biological active peptide in preparation of medicine for preventing and treating arthritis |
07/12/2006 | CN1799621A Pain relieving oral liquor |
07/12/2006 | CN1799619A Chinese medicinal gel formulation and its preparing process |
07/12/2006 | CN1799613A Chinese medicine for treating damp heat arthralgia and its preparation method |
07/12/2006 | CN1799612A Novel drug administering route of 'Qu Gan Re' injection, its preparation process and novel indications |
07/12/2006 | CN1799609A Soft capsule formulation containing gastrodia tuber medicinal composition and preparation method thereof |
07/12/2006 | CN1799603A Chinese traditional medicine composition for treating rheumatic or rheumatoid disease and preparation method thereof |
07/12/2006 | CN1799600A Ointment for treating swelling and pain by traumatic injury and preparation process thereof |
07/12/2006 | CN1799586A Cold treating capsule and its preparation method |
07/12/2006 | CN1799585A Intravenous administered formulation of spreading hedyotis herb and its preparation method |
07/12/2006 | CN1799584A Chinese medicinal composition, its preparation process and quality control method |
07/12/2006 | CN1799579A Chinese medicinal dispersible tablet, its preparation process and quality control method |
07/12/2006 | CN1799576A Chinese medicinal extract, its preparation process and quality control method |
07/12/2006 | CN1799575A Chinese medicinal dispersible tablet, its preparation process and quality control method |
07/12/2006 | CN1799557A Chinese medicinal gel formulation, its preparation process and quality control method |
07/12/2006 | CN1263768C New taraxerol derivative and its preparation and use |
07/12/2006 | CN1263763C Process for extracting ginkgolide |
07/12/2006 | CN1263760C Novel buprenorphine ester derivatives and process for preparing the same and medical composition with long-acting analgesic effect |
07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
07/12/2006 | CN1263751C Novel compounds |
07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
07/12/2006 | CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels |
07/12/2006 | CN1263498C Medicine for treating arthraligia caused by wind, cold and wetness evils and with weight-reducing function and its preparing method |
07/12/2006 | CN1263446C Self emulsifying lipid matrix (SELM) |
07/11/2006 | US7074939 Indole derivatives as anti-inflammatory agents |
07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
07/11/2006 | US7074894 Antigen composition against mycoplasma |
07/11/2006 | US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis |
07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
07/11/2006 | US7074790 Antiinflammatory agents; autoimmune disease |
07/11/2006 | US7074783 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders |
07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
07/11/2006 | US7074435 Crude drug compositions for treating or preventing arthritic diseases and the preparation process |
07/11/2006 | US7074430 Oral administering |
07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
07/11/2006 | CA2319201C Celecoxib compositions |
07/11/2006 | CA2290830C Process |
07/11/2006 | CA2285548C Nicotinamide derivatives |
07/11/2006 | CA2274074C Novel compounds with analgesic effect |
07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
07/11/2006 | CA2157921C Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
07/06/2006 | WO2006071958A1 Compounds useful as chemokine receptor antagonists |
07/06/2006 | WO2006071819A1 [1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
07/06/2006 | WO2006071653A1 Method of reducing oral tissue inflammation using magnolia extract |
07/06/2006 | WO2006071601A2 Therapeutic compositions for intranasal administration of ketorolac |
07/06/2006 | WO2006071091A1 Humanized antibody specific for tumor necrosis factor-alpha |
07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
07/06/2006 | WO2006070891A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
07/06/2006 | WO2006070873A1 Adiponectin inducer or secretagogue |
07/06/2006 | WO2006070672A1 Hydrous adhesive patch |
07/06/2006 | WO2006070106A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
07/06/2006 | WO2006070001A1 Substituted indole ligands for the orl-1 receptor |
07/06/2006 | WO2006069419A1 Nanoparticle composition and methods for synthesis thereof |
07/06/2006 | WO2006057900A3 17,20(z)-dehydro vitamin d analogs and their uses |
07/06/2006 | WO2006057899A3 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
07/06/2006 | WO2006053784A3 1,7-naphthyridines as pde4 inhibitors |